 There are no
data on unoperated-on controls for comparison. The lack
of high-quality data on the treatment of stroke in evolution
precludes any clear conclusions on the management of this
group of patients. There has not been a significant experience with CAS in these patients, distinct from what is
referenced above for acute stroke, to draw conclusions.
3. Crescendo TIA. This relatively rare clinical syndrome is characterized by repetitive episodes of transient
neurologic ischemia,